As long as price holds above today’s low, I see immediate potential for the bullish scenario outlined on the chart, with a possible re-test of the Feb ’25 all-time highs in coming weeks.
Alternatively, a break below today’s low and the recent Jul higher low would shift probabilities in favor of further downside, potentially even below Jun lows.
Will regulatory risk dominate after the Novo Nordisk controversy, or will diversification into areas like low testosterone, menopause, longevity, and sleep health along with investment in AI-driven healthcare help stabilize the narrative?
From a price structure standpoint: • If July higher lows form and 57 support holds: I see potential for upside toward 62–66, possibly retesting ATH • If noe: one more leg down to the 38–34 zone remains on the table
HIMS the life in it is gone for today so more possibility of selling I think. It could go below 46.5$ and if hard selling continues then below 43.5$ where strong buyers would emerge
HIMS
